BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20034675)

  • 1. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders.
    Lévy-Rueff M; Gourevitch R; Lôo H; Olié JP; Amado I
    Psychiatry Res; 2010 Feb; 175(3):280-3. PubMed ID: 20034675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G; Kocsis-Ficzere N; Tolna J
    Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective study of 935 sessions of electroconvulsive therapy (1989-91)].
    Planche R; Planche F; Patedoye E; Charbonnier JF; Dissait F; Reynaud M
    Ann Med Psychol (Paris); 1992 Dec; 150(10):730-3; discussion 733-4. PubMed ID: 1343501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of electroconvulsive therapy in the adolescent].
    Cohen D; Dubos PF; Basquin M
    Encephale; 1997; 23(4):308-11. PubMed ID: 9417397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of electroconvulsive therapy in adolescents.
    Cohen D; Paillère-Martinot ML; Basquin M
    Convuls Ther; 1997 Mar; 13(1):25-31. PubMed ID: 9152585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of electroconvulsive therapy in restrictive indications. A retrospective study of 15 years].
    Schott K; Bartels M; Heimann H; Buchkremer G
    Nervenarzt; 1992 Jul; 63(7):422-5. PubMed ID: 1501720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECT in acute delirium and related clinical states.
    Strömgren LS
    Convuls Ther; 1997 Mar; 13(1):10-7. PubMed ID: 9152583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maintenance electroconvulsive therapy--a review of literature].
    Palińska D; Makowska I; Sobów T; Hese RT; Kłoszewska I
    Psychiatr Pol; 2008; 42(6):819-24. PubMed ID: 19441661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follow-up of schizophrenic patients hospitalized for the first time in 1954 and treated with electroconvulsive therapy].
    Lingg A; Haller R
    Psychiatr Prax; 1987 Nov; 14(6):207-11. PubMed ID: 3423154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term weekly continuation electroconvulsive therapy: a case series.
    Zisselman MH; Rosenquist PB; Curlik SM
    J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is electroconvulsive therapy obsolete?].
    König P; Angelberger-Spitaler H; Conca A; Schneider HJ
    Wien Klin Wochenschr; 1991; 103(7):201-6. PubMed ID: 2063585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECT in elderly patients with schizophrenia.
    Kramer BA
    Am J Geriatr Psychiatry; 1999; 7(2):171-4. PubMed ID: 10322246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia.
    Chanpattana W; Chakrabhand ML; Kitaroonchai W; Choovanichvong S; Prasertsuk Y
    J Med Assoc Thai; 1999 May; 82(5):477-83. PubMed ID: 10443097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
    Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
    J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ECT the treatment of choice for first-break psychosis?
    Kellner CH
    Convuls Ther; 1995 Sep; 11(3):155-7. PubMed ID: 8528656
    [No Abstract]   [Full Text] [Related]  

  • 20. Electroconvulsive therapy in adolescent and adult psychiatric inpatients--a retrospective chart design.
    Stein D; Kurtsman L; Stier S; Remnik Y; Meged S; Weizman A
    J Affect Disord; 2004 Nov; 82(3):335-42. PubMed ID: 15555684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.